Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-008833
Filing Date
2020-09-18
Accepted
2020-09-18 16:09:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27656
2 filename2.txt TEXT-EXTRACT 1500
  Complete submission text file 0000000000-20-008833.txt   40262
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filed for) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations